Future outperforming subsectors in pharma

Future outperforming subsectors in pharma

Oncology, immunology & neurology will outperform the overall pharmaceutical sector over the coming decade. Innovation will drive this out-performance. IQVIA estimates annual spending on oncology and immunology will reach US$ 273bn and US$ 175bn respectively, with over 100 new...

Continue reading →